Autonomous capability can expand via new tools, memory, prompts, and delegation despite unchanged models, necessitating ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated ...
In today's ACT Brief, we examine how data drives honest enrollment assumptions, why RWE infrastructure lags ambition, and the ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains why combining analog trial performance ...
RWE is finding a role earlier in drug development than ever before, but the data quality, integration, and organizational ...
In this Q&A, Sylviane de Viron of CluePoints and Abigail Dirks, MS, of Tufts CSDD discuss the findings of a collaborative ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains how AI is expanding endpoint selection ...
In part three of her DPHARM interview, Andrea Valente, CEO of uMotif, explains why truly understanding the patient journey ...
In today's ACT Brief, we examine how AI is surfacing endpoint options beyond traditional design thinking, why sponsor ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains why combining analog trial performance data with real-world patient data and site-level recruitment history gives ...
In part two of her DPHARM interview, Andrea Valente, CEO of uMotif, explains why the real technology challenge isn't ...
In today's ACT Brief, we examine what patient-site relationships need most at DPHARM, how platform-based AI scales across ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results